MetLife Investment Management, LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in CADL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$79,375

-$30,477 QoQ

Shares Held

16,199

-16.7% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. CADL ranks #199 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	70,804	$31,616,818
2	PRAX	Praxis Precision Medicines, Inc.	80,930	$26,074,836
3	AXSM	Axsome Therapeutics, Inc.	152,645	$25,800,057
4	HALO	Halozyme Therapeutics, Inc.	374,931	$24,231,790
5	REGN	Regeneron Pharmaceuticals, Inc.	23,567	$18,208,806
6	FTRE	Fortrea Holdings Inc.	1,805,184	$17,004,833
7	ADMA	Adma Biologics, Inc.	1,738,062	$15,659,938
8	VRDN	Viridian Therapeutics, Inc.\DE	708,527	$13,858,788

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$79,375	16,199	-16.7%	Shares	Defined	2026-05-14
2025-12-31	$109,852	19,443	+25.5%	Shares	Defined	2026-02-12
2025-09-30	$78,988	15,488	-39.4%	Shares	Defined	2025-11-13
2025-06-30	$129,262	25,546	+67.8%	Shares	Defined	2025-08-13
2025-03-31	$86,032	15,227	+10.6%	Shares	Defined	2025-05-14
2024-12-31	$119,549	13,773	+9.7%	Shares	Defined	2025-02-13
2024-09-30	$87,026	12,558	—	Shares	Defined	2024-11-13
No filing history on record for this holder in this stock.